Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
PR Newswire•14/08/2026•16:30 ET
0
Whiz Insights
Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
$7.1 million in revenue for the first nine months of fiscal 2026 as the LYMPHIR(®) launch progresses
Get started
Create a free account to read the full story.